• Kupando raises €10M in Series A extension to advance innate immunity drug
Remiges Ventures - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

Top Publishers

Top Creators

  • Ryan Allis

    Ryan Allis

    194 followers

  • Elon Musk

    Elon Musk

    78 followers

  • Sam Altman

    Sam Altman

    68 followers

  • Mark Cuban

    Mark Cuban

    56 followers

  • Jack Dorsey

    Jack Dorsey

    39 followers

See More →

Top Companies

  • SaasRise

    SaasRise

    196 followers

  • Anthropic

    Anthropic

    39 followers

  • OpenAI

    OpenAI

    21 followers

  • Hugging Face

    Hugging Face

    15 followers

  • xAI

    xAI

    12 followers

See More →

Top Investors

  • Andreessen Horowitz

    Andreessen Horowitz

    16 followers

  • Y Combinator

    Y Combinator

    15 followers

  • Sequoia Capital

    Sequoia Capital

    12 followers

  • General Catalyst

    General Catalyst

    8 followers

  • A16Z Crypto

    A16Z Crypto

    5 followers

See More →
NewsDealsSocialBlogsVideosPodcasts
HomeRemiges Ventures
Remiges Ventures logo

Remiges Ventures

0 followers

About Remiges Ventures

Remiges Ventures is a biotech-focused venture capital firm that backs early-stage and growth opportunities in drug discovery and life sciences. The firm highlights its portfolio companies and strategic collaborations across therapeutic areas, including gene therapy and neurological and cancer indications, with activity and investments reportedly centered in the biopharma ecosystem. Through its RDiscovery Fund and related initiatives, Remiges aims to incubate and support breakthrough scientific ventures from discovery through clinical development, leveraging its deep domain expertise. The company maintains information and updates on its activities via its website, including news and team pages, and engages with the broader biotech community online.

Recent News

No recent news for this company.

Recent Deals

Kupando Raises €10M in Series A Extension to Advance Innate Immunity Drug

March 18, 2026

Key Team Members

Stephen Gitto

Director of Finance

Taro Inaba

Managing Partner

Walter Olesiak

Operating Partner

Takaaki Tobaru

Partner

Taka Koda

Partner

Key Facts

HQ Location

Seattle, United States

Founded

2019

Employees

1 - 10

Status

Investor

Investor Type

Venture Investor

Website

https://remigesventures.com